Stock OWCP OWC PHARMACEUTICAL RESEARCH CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News OWC Pharmaceutical Research Corp. Other OTC

Equities

OWCP

US67109N1081

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
OWC PHARMACEUTICAL RESEARCH CORP. : Change in Directors or Principal Officers (form 8-K)
AQ
OWC Pharmaceutical Research Corp. Announces Resignation of David Kugelman as the Sole Director
CI
Discover Growth Enters into Agreement with OWC Pharmaceutical
CI
Discover Growth Provides Information to Shareholders of OWC Pharmaceutical
CI
OWC PHARMACEUTICAL RESEARCH CORP. : Changes in Control or Registrant, Change in Directors or Principal Officers (form 8-K)
AQ
OWC Pharmaceutical Research Corp. Announces Board Changes
CI
Discover Growth Seeks to Replace Directors at OWC Pharmaceutical
CI
Discover Growth Intends to Vote to Replace the Board of OWC Pharmaceutical
CI
OWC PHARMACEUTICAL RESEARCH CORP. : Other Events (form 8-K)
AQ
OWC PHARMACEUTICAL RESEARCH : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K/A)
AQ
OWC Pharmaceutical Research Corp. Announces the Resignation of Shmuel De-Saban from the Board of Directors
CI
OWC PHARMACEUTICAL RESEARCH CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
OWC PHARMACEUTICAL RESEARCH CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
OWC Pharmaceutical Research Corp. Announces New Distribution Agreement with Can It Industries
CI
OWC PHARMACEUTICAL RESEARCH CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
OWC Pharmaceutical Research Corp. : Letter to Shareholders for Upcoming Proxy Voting
PR
OWC Pharmaceutical Research Corp. : Announces Special Meeting of Stockholders
PR
OWC PHARMACEUTICAL RESEARCH CORP. : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
OWC Pharmaceutical Research Corp. Announces Board Changes
CI
OWC Pharmaceutical Research Corp. Appoints Shmuel De-Saban as Chief Financial Officer of the Company, Effective July 1, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OWCP Stock
  4. OWCP Stock
  5. News OWC Pharmaceutical Research Corp.